Screener
Inhibrx Biosciences, Inc. INBX Business Segments — Other general and administrative
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherGeneralAndAdministrativeExpense.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Other research and development | (2,906) | (3,153) |
| Total research and development expense | (25,217) | (36,877) |
| General and administrative expense | ||
| Personnel | (3,646) | (3,777) |
| Other general and administrative | (2,064) | (2,247) |
| Total general and administrative expense | (5,710) | (6,024) |
| Other expense | (2,514) | (410) |
| Segment and consolidated net loss | $(33,441) | $(43,311) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s business segments — other general and administrative?
- Inhibrx Biosciences, Inc. (INBX) reported business segments — other general and administrative of $2.06M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s business segments — other general and administrative changed year-over-year?
- Inhibrx Biosciences, Inc.'s business segments — other general and administrative decreased by 8.1% year-over-year, from $2.25M to $2.06M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s business segments — other general and administrative?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s business segments — other general and administrative has grown at a -12.8% compound annual growth rate (CAGR), from $11.58M to $8.82M.
- What does business segments — other general and administrative mean?
- Captures general administrative and overhead expenses allocated to the segment that are not directly tied to research or manufacturing. It serves as a measure of the segment's operational efficiency and corporate support burden.
Ask your AI about Inhibrx Biosciences, Inc.'s business segments — other general and administrative.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude